Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interaction of Polymorphism rs35652124 With Curcumin Supplementation on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function in Patients With Early Diabetic Nephropathy

NCT03262363 is registered in ClinicalTrials.gov with Unidad de Investigacion Medica en Enfermedades Renales as lead sponsor.

NCT NCT03262363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03262363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interaction of Polymorphism rs35652124 With Curcumin Supplementation on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function in Patients With Early Diabetic Nephropathy
Lead sponsor
Unidad de Investigacion Medica en Enfermedades Renales
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 1, 2018
Completion date
April 30, 2019
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes mellitus, type 2, polymorphism